Section Arrow
Quote
MLTX.NASDAQ
- MoonLake Immunotherapeutics
Quotes are at least 15-min delayed:2025/11/22 20:57 EST
Regular Hours
Last
 12.67
-0.33 (-2.54%)
Day High 
13.1899 
Prev. Close
13 
1-M High
13.99 
Volume 
2.31M 
Bid
12.5
Ask
12.72
Day Low
12.43 
Open
13 
1-M Low
8.9 
Market Cap 
921.02M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.42 
20-SMA 11.22 
50-SMA 19.85 
52-W High 62.75 
52-W Low 5.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.33/-3.00
Enterprise Value
922.47M
Balance Sheet
Book Value Per Share
4.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OSRHOSR Holdings Inc.0.5626+0.1066+23.38%-- 
SGMOSangamo Therapeutics0.4234+0.0384+9.97%-- 
RXRXRecursion Pharmaceuticals4.17+0.32+8.31%-- 
CYPHCypherpunk Technologies Inc.2.28-0.66-22.45%-- 
ASBPAspire Biopharma Holdings Inc.0.0974-0.0003-0.31%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.